News
-
-
PRESS RELEASE
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
ONWARD Medical N.V. announces groundbreaking advancements in blood pressure regulation after Spinal Cord Injury with ARC-IM Therapy, supported by clinical evidence in Nature and Nature Medicine -
-
PRESS RELEASE
Finnish-born FinTech Multitude AG Celebrates 20 Years of Growth and 10 Years on the Frankfurt Stock Exchange
Multitude AG, a European FinTech company, celebrates its 20th anniversary with customers, partners, and employees in Finland. Operating in 17 countries, with revenue of EUR 263.7 million in 2024 -
-
-
PRESS RELEASE
DEAG: Subscription period for new Corporate Bond 2025/2029 begins today – “Entertainment with yield”
DEAG begins subscription period for new Corporate Bond 2025/2029, offering a fixed interest rate of 7.00% - 8.00% p.a. Investors can subscribe through DirectPlace until 8 October 2025. Use of proceeds for refinancing and growth -
PRESS RELEASE
FDA minutes confirm positive outcome of meeting on 9. September 2025 – Corticorelin on track for Phase 3
Curatis Holding AG receives positive outcome confirmation from FDA meeting regarding corticorelin's Phase 3 development plan for patients with PTBE secondary to solid tumor brain metastases -
PRESS RELEASE
AEVIS VICTORIA SA – Chiffre d’affaires en forte progression au premier semestre 2025. Le cash flow libre dépasse les CHF 100 millions permettant un désendettement de plus de CHF 120 millions.
AEVIS VICTORIA SA rapporte une forte augmentation du chiffre d'affaires au premier semestre 2025, avec un cash flow libre dépassant CHF 100 millions et un désendettement de plus de CHF 120 millions -
